[Form 4] Life360, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Charles J. Prober, a director of Life360, Inc. (LIF), reported routine insider transactions executed under a pre-established Rule 10b5-1 trading plan adopted March 14, 2025. On 08/13/2025 the filing shows a stock option exercise/acquisition of 7,930 shares at an exercise price of $11.18, which increased his beneficial ownership to 113,386 shares (this total includes 2,714 restricted stock units). The same day the plan shows the sale of 7,930 shares at $84.13, leaving him with 105,456 shares beneficially owned following the reported transactions. The Form 4 is signed by an attorney-in-fact on 08/15/2025.

Positive

• Transactions executed under a documented Rule 10b5-1 plan, adopted March 14, 2025, supporting pre-established trading intent
• Option exercise at $11.18 demonstrates insider converted compensation into shares before sale
• Filing discloses RSUs (2,714) and vesting schedule, improving transparency about outstanding compensation

Negative

• Insider sale of 7,930 shares at $84.13 on 08/13/2025 reduced beneficial ownership to 105,456 shares

Insights

Securities Analyst

TL;DR: Director exercised options at $11.18 and sold the resulting shares via a 10b5-1 plan at $84.13 on 08/13/2025.

The filing documents a concurrent exercise of a stock option and an automatic sale under a Rule 10b5-1 plan. Exercising at $11.18 and immediately selling at $84.13 suggests the transactions were mechanical under the pre-set plan rather than opportunistic market-timing by the insider. The report also discloses 2,714 restricted stock units included in the beneficial ownership total, and the option’s vesting schedule is described in the filing. For investors, this is a routine Section 16 disclosure of insider liquidity and option exercise activity.

Corporate Governance Expert

TL;DR: Transaction executed under documented 10b5-1 plan; reporting meets Section 16 disclosure norms.

The disclosure explicitly states the trades were effected pursuant to a Rule 10b5-1 plan adopted while the reporting person was not aware of material nonpublic information, which supports the affirmative defense. The form includes clear counts of shares before and after the transactions and notes restricted stock units and option vesting terms. This filing is procedural and consistent with established insider trading policies.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Prober Charles J.

(Last) (First) (Middle)

C/O LIFE360, INC.

1900 SOUTH NORFOLK STREET, SUITE 310

(Street)

SAN MATEO CA 94403

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Life360, Inc. [ LIF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock	08/13/2025		M(1)		7,930	A	$11.18	113,386(2)	D
Common stock	08/13/2025		S(1)		7,930	D	$84.13	105,456(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$11.18	08/13/2025		M(1)			7,930	(3)	04/12/2028	Common stock	7,930	$0	118,950	D

Explanation of Responses:

1. The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.

2. Includes 2,714 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

3. The stock option vests and becomes exercisable as to 1/2 of the total number of shares on April 12, 2024 and thereafter vests and becomes exercisable as to 1/48th of the total number of shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.

Remarks:

	/s/ Jay Sood, Attorney-in-Fact	08/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did Life360 (LIF) report on Form 4?

The Form 4 reports that director Charles J. Prober exercised 7,930 stock options at $11.18 and sold 7,930 shares at $84.13 on 08/13/2025 under a Rule 10b5-1 plan.

Was the trade made under a Rule 10b5-1 plan for LIF?

Yes. The filing states the transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on March 14, 2025.

How many Life360 shares does Charles J. Prober beneficially own after the transactions?

Following the reported transactions, the filing shows he beneficially owned 105,456 shares.

Does the Form 4 disclose restricted stock units or other equity awards for the reporting person?

Yes. The filing notes it includes 2,714 restricted stock units that represent contingent rights to receive common stock upon vesting.

Who signed the Form 4 for the reporting person and when?

The Form 4 was signed by Jay Sood, Attorney-in-Fact on 08/15/2025.